Clinical phase II trial to evaluate the safety and efficacy of clofarabine and treosulfan conditioning prior to peripheral blood stem cells transplantation in paediatric and adult patients with advanced haematological malignancies.
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2015
At a glance
- Drugs Clofarabine (Primary) ; Treosulfan (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 17 Oct 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 03 Aug 2011 New trial record